A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2001
11/22/2001	CA2408961A1 Use of ajulemic acid and related cannabinoids for the treatment of cancer
11/22/2001	CA2408837A1 New use of citreamicins
11/22/2001	CA2408830A1 Treatment of human papillomavirus (hpv)-infected cells
11/22/2001	CA2408756A1 Immune potentiating compositions
11/22/2001	CA2408745A1 Anti-angiogenic polypeptides
11/22/2001	CA2408617A1 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	CA2408530A1 Novel deoxynucleoside kinase enzyme variants
11/22/2001	CA2408408A1 Modulators of tnf- alpha signaling
11/22/2001	CA2408383A1 Use of ellagic acid as anti-pollution cosmetic agent
11/22/2001	CA2408360A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	CA2407469A1 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
11/22/2001	CA2407104A1 Method to increase class i presentation of exogenous antigens by human dendritic cells
11/22/2001	CA2407099A1 Aralkyl ester soft drugs
11/22/2001	CA2406013A1 Treatment of autoimmune, proliferative and inflammatory diseases with compositions of non-ionic copolymers
11/21/2001	EP1156119A2 Anti-cancer gene therapy by modulation of immune or inflammatory response
11/21/2001	EP1156118A1 Virus vector
11/21/2001	EP1156110A2 G-protein coupled receptor (HFGAN72Y)
11/21/2001	EP1156056A1 5-GLYCOSYLOXY-6-HYDROXYNAPHTHO 2,3-f]QUINOLINE-7,12-DIONE HAVING ANTICANCER ACTIVITIES
11/21/2001	EP1156049A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
11/21/2001	EP1156046A1 Benzo(5,6)cyclohepta(1,2-B)pyridine derivatives for the inhibition of farnesyl protein transferase
11/21/2001	EP1155692A1 Use of Paclitaxel stabilized with albumin for preparing a drug for the treatment of solid tumors and the drug obtained thereby
11/21/2001	EP1155691A2 Anti-angiogenic compositions and methods of use
11/21/2001	EP1155690A2 Anti-angiogenic compositions and method of use
11/21/2001	EP1155689A2 Anti-angiogenic compositions and methods of use
11/21/2001	EP1155030A1 Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase
11/21/2001	EP1155025A1 Platinum (ii) compounds
11/21/2001	EP1155021A1 Hesperitin pro-forms with enhanced bioavailability
11/21/2001	EP1155012A1 Anti-cancer dihydroquinazoline derivatives
11/21/2001	EP1155003A1 Novel guanidine derivatives as inhibitors of cell adhesion
11/21/2001	EP1155000A1 2-aminopyridines containing fused ring substituents
11/21/2001	EP1154997A1 Pharmaceutically active compounds and methods of use thereof
11/21/2001	EP1154819A2 Treatment regimen for hormone-sensitive cancers
11/21/2001	EP1154803A1 Immobilized labeling compounds and methods
11/21/2001	EP1154798A1 Molecules for the treatment and diagnosis of tumors
11/21/2001	EP1154788A1 Inhibitors of separin, method for identifying them and uses
11/21/2001	EP1154774A1 Quinazoline derivatives as angiogenesis inhibitors
11/21/2001	EP1154769A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen
11/21/2001	EP1154767A1 Substituted stilbene compounds with vascular damaging activity
11/21/2001	EP1154764A1 Epoxide hydrolase complexes and methods therewith
11/21/2001	EP0952974B1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
11/21/2001	EP0931079B1 Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase
11/21/2001	EP0854727B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
11/21/2001	EP0832082B1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
11/21/2001	EP0802911B1 Hydrophobic taxane derivatives
11/21/2001	EP0765168B1 Combination of a procoagulant and a cytokine or an inducer of cytokine production for the treatment of tumors
11/21/2001	EP0708642B1 Taxol derivatives
11/21/2001	CN1323350A Adenovirus vectors containing cell status-specific response elements and methods of use thereof
11/21/2001	CN1323314A Inhibitors of caspases
11/21/2001	CN1323310A Photocyclized rapamycins
11/21/2001	CN1323309A Phenyl yanthine derivatives
11/21/2001	CN1323301A Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
11/21/2001	CN1323298A New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists
11/21/2001	CN1323225A Polymer conjugates of interferon beta-1a and their uses
11/21/2001	CN1323217A Methods for therapeutic vaccination
11/21/2001	CN1323216A Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
11/21/2001	CN1323202A Sertraline oral concentrate
11/21/2001	CN1323199A Liposome-entrapped topoisomerase inhibitors
11/21/2001	CN1322824A New polypeptide human aldehyde/ketone reductase 12 and its encoding polynucleotides
11/21/2001	CN1322818A New polypeptide human class-II aminoacyl-tRNA synthetase 10 and encoding polynucleotide of the same polypeptide
11/21/2001	CN1322755A New polypeptide human Pax protein 9 and its encoding polynucleotides
11/21/2001	CN1322752A New polypeptide human Pax protein 22 and its encoding polynucleotides
11/21/2001	CN1322749A New polypeptide human ribosomal protein S18-12 and its encoding polynucleotide
11/21/2001	CN1322745A New polypeptide human gap junction protein 15 and its encoding polynucleotide
11/21/2001	CN1322744A New polypeptide human CCR4 related protein 10 and its encoding polynucleotides
11/21/2001	CN1322738A New polypeptide human cannabol receptor 11 and its encoding polynucleotides
11/21/2001	CN1322732A New liver cancer up expressing gene and its encoded protein and application
11/21/2001	CN1322729A Acylated derivative of dioscin and its producing process and use
11/21/2001	CN1322719A MYT1 kinase inhibitor
11/21/2001	CN1322568A Lung cancer treating medicine
11/21/2001	CN1322567A Aikangning medicine for treating cancer
11/21/2001	CN1322558A Liver cancer resisting medicine
11/21/2001	CN1075078C Producing process of stem cell factor
11/21/2001	CN1075066C Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
11/21/2001	CN1075059C Colchicine derivatives and its therapeutical use
11/21/2001	CN1074898C Ionene polymers, producing process, its intermediate and use
11/20/2001	US6320074 In vivo modulation of lipid metabolism, skin-related processes, autoimmune diseases, fatty acid metabolism, malignant cell development, premalignant lesions, or programmed cell death
11/20/2001	US6320054 Thiazole derivatives
11/20/2001	US6320036 GbpA
11/20/2001	US6320022 Adrenomedullin peptides
11/20/2001	US6319956 N1, n4-bis(cyclopropylmethylamino)trialkylenetetramines that may be toluenesulfonated.
11/20/2001	US6319947 Vanadium (IV) metallocene complexes having spermicidal activity
11/20/2001	US6319943 Oral formulation for paclitaxel
11/20/2001	US6319930 Substituted dimeric compounds
11/20/2001	US6319923 Method of treating a tumor
11/20/2001	US6319922 Propanoic acid derivatives
11/20/2001	US6319918 For lymphoma or solid tumors treatment
11/20/2001	US6319910 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
11/20/2001	US6319900 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
11/20/2001	US6319689 Nucleotide sequence which code aspartic protease; for treatment of alzheimer's disease, cancer; for hormone processing
11/20/2001	US6319688 Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1)
11/20/2001	US6319667 Diagnostics and therapy of diseases associated with HHV-8 infections
11/20/2001	US6319496 Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
11/19/2001	CA2308994A1 Neuroprotective compounds
11/18/2001	CA2345482A1 Use of paclitaxel stabilized with albumin for preparing a drug for the treatment of solid tumors and the drug obtained thereby
11/15/2001	WO2001086307A2 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
11/15/2001	WO2001085995A2 Identification of neural defects associated with the nucleosom al assembly protein 1l2 gene
11/15/2001	WO2001085986A2 Phosphatidyl inositol 3-kinase delta binding partner
11/15/2001	WO2001085980A2 Enzymatic assays for screening anti-cancer agents
11/15/2001	WO2001085960A1 Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy
11/15/2001	WO2001085959A2 Regulation of human lysostaphin-like protease

1 ... 1771 1772 1773 1774 1775 1776 1777 1778 1779 1780 1781 1782 1783 1784 1785 1786 1787 1788 1789 1790 1791 ... 2211